Search

everythinglearnresearchcommunity

for

Search:↓

Women in Australia report different signs of facial aging compared to women in the US, UK, and Canada; men with Lichen planopilaris often have hormonal abnormalities and thyroid disease.

Tailored treatments for alopecia areata show promising results, with pulse steroids effective for mild cases and Ritlecitinib, Dupilumab, or methotrexate and prednisone effective for severe cases.

Recognizing and treating overlap syndrome in connective tissue diseases is crucial.

A woman developed lupus after taking hydroxyurea for two years.

Early treatment with the right dose of stem cells can reduce lupus symptoms.

A man developed autoimmune symptoms after the Pfizer COVID-19 vaccine, highlighting the need for thorough vaccine safety checks.

S100A7 and IL-17 may contribute to inflammation in lichen planopilaris.

Apremilast helps regrow hair in hard-to-treat alopecia areata.

Drugs targeting EMT molecules show promise for treating lichen planopilaris.

Oral lichen planus is a chronic disease causing mouth discomfort and sometimes needs immunosuppressive treatment.

The C3H/HeJ mouse model is useful for studying and testing treatments for alopecia areata.

Acitretin effectively treats severe hypertrophic lichen planus.

Rhupus is a complex syndrome that combines rheumatoid arthritis and lupus, making diagnosis challenging.

Systemic lupus erythematosus caused severe abdominal issues in a Sudanese woman.

Belimumab effectively controls SLE disease activity and reduces steroid use.

Progesterone initially worsens but later reduces neuropathic pain in mice, through different mechanisms.

Patients with lichen planopilaris have a higher risk of heart disease.

New tools were created to help lupus patients report their symptoms and impacts more accurately.

A woman with skin and joint issues progressed from one type of lupus to another, highlighting the need to recognize complex conditions.

Alopecia areata is influenced by genetics and immune system factors, and better understanding could improve treatments.

The patient has Chronic Cutaneous Lupus, a skin condition causing plaques and hair loss.

Guselkumab effectively treats skin reactions caused by adalimumab in certain conditions.

Ruxolitinib can cause a delayed skin reaction on the nose.

Intravenous cyclophosphamide effectively treated steroid-resistant lupus cystitis and peritonitis.

A woman with lupus and Kikuchi-Fujimoto disease improved with treatment.

Abrocitinib effectively treats severe alopecia areata with significant improvement and no side effects.

Suplatast tosilate successfully treated a woman's systemic sclerosis symptoms.

A woman with lupus experienced hair regrowth after treatment, but hair transplantation is not advised for her condition.

Dupilumab significantly improved a 5-year-old girl's prurigo nodularis without side effects.

A new minoxidil regimen improved hair loss in a lupus patient.